Back to Market Feed

Product Information

STELARA 90 MG/ML SYRINGE is a brand product labeled by Janssen Biotech, Inc., priced at $29792.7867 per ML under NDC 57894006103. Its NADAC has been published 655 times since Nov 28, 2013.

STELARA 90 MG/ML SYRINGE

ustekinumab
$29792.7867per ML

Strength

90 mg/mL

NDC

57894006103

Classification

Brand

Dosage Form

INJECTION, SOLUTION

Route

SUBCUTANEOUS

Effective Date

8/19/2026

Active Ingredients

USTEKINUMAB

Approval Type

Biologic (BLA)

FDA Application

BLA125261

On Market Since

9/25/2009

Pharmacological Classes

Interleukin-12 Antagonist
Interleukin-12 Antagonists
Interleukin-23 Antagonist
Interleukin-23 Antagonists

Price Statistics

The NADAC for STELARA 90 MG/ML SYRINGE has been published 655 times since Nov 28, 2013, and over the history we have for it it has risen 130.0%. The table below summarizes its recorded NADAC range and movement.

Current price$29792.7867 per ML
All-time high$29843.8000 (Aug 12, 2026)
All-time low$12951.1987 (Nov 28, 2013)
52-week high$29843.8000
52-week low$28361.0058
Median price$22344.1917
Average price$21732.1426
Largest weekly change+10.4% (Aug 19, 2015)
Weeks tracked655
Tracking sinceNov 28, 2013

Price History

1W

-0.2%

1M

-0.2%

3M

-0.0%

6M

-0.0%

1Y

+5.0%

3Y

+16.5%

5Y

+27.6%

All

+130.0%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ustekinumab market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

TREMFYA 200 MG/2 ML PEN
Brand
57894065102•Janssen Biotech, Inc.
$7318.9883
per ML
TREMFYA 100 MG/ML SYRINGE
Brand
57894064001•Janssen Biotech, Inc.
$14728.9053
per ML
TREMFYA 100 MG/ML ONE-PRESS
Brand
57894064011•Janssen Biotech, Inc.
$14745.8421
per ML
SKYRIZI 150 MG/ML PEN
Brand
00074210001•AbbVie Inc.
$22761.4629
per ML
SKYRIZI 150 MG/ML SYRINGE
Brand
00074105001•AbbVie Inc.
$22887.4386
per ML

Frequently asked questions

What is the NADAC price of STELARA 90 MG/ML SYRINGE?

The current National Average Drug Acquisition Cost (NADAC) for STELARA 90 MG/ML SYRINGE, manufactured by Janssen Biotech, Inc., is $29792.7867 per ML (NDC 57894006103), effective Aug 19, 2026.

How has the price of STELARA 90 MG/ML SYRINGE changed over time?

Over the history we have for it, the NADAC for STELARA 90 MG/ML SYRINGE has risen 130.0%. It has been tracked across 655 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for STELARA 90 MG/ML SYRINGE?

Since Nov 28, 2013, the NADAC for STELARA 90 MG/ML SYRINGE has ranged from a low of $12951.1987 (Nov 28, 2013) to a high of $29843.8000 (Aug 12, 2026), with a median of $22344.1917 per ML.

Are there cheaper alternatives to STELARA 90 MG/ML SYRINGE?

No other NADAC-published product currently shares the active ingredient and strength of STELARA 90 MG/ML SYRINGE in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures STELARA 90 MG/ML SYRINGE?

STELARA 90 MG/ML SYRINGE (NDC 57894006103) is labeled by Janssen Biotech, Inc., and CMS classifies it as a brand product.